Tech Company Financing Transactions

Five Prime Therapeutics Funding Round

Five Prime Therapeutics closed a $12 million Series B funding round on 9/23/2003. Backers included Kleiner Perkins Caufield & Byers, TPG Capital and Advanced Technology Ventures.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

111 Oyster Point Blvd.
South San Francisco, CA 94080
USA

Phone

(415) 365-5600

Website

www.fiveprime.com

Email Address

[email protected]

Overview

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

William Ringo

        

Chief Financial Officer

David Smith

        

Chief Medical Officer

Helen Collins

        

VP - Bus. Development

Francis Sarena

        

VP - Operations

Nallakkan Arvindan

        

Browse more venture capital transactions:

Prev: 9/23/2003: Asteres venture capital transaction
Next: 9/24/2003: InfiniCon Systems venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary